E5H-29947-86736
2 vaccinations
4 coded responses
28 check-ins
4 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 05-11
- ZIP prefix
- 672 / KS
- Registered
- 2022-01-04
- Relationship
- Child or adolescent in my care
- Guardian
- 272-10257-34774
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-01-04
Registered in v-safe
-
2022-01-04
Dose 1 — Pfizer-BioNTech
- 2022-01-04
- 2022-01-05
- 2022-01-06
-
2022-01-07
Survey response — days 1–6 daily, dose 1, dependentMedDRA: Urticaria — Feeling: GoodFree text: Random hives come and goMedDRA releases: 2024-11 · check-in free text available
- 2022-01-08
-
2022-01-09
Survey response — days 1–6 daily, dose 1, dependentMedDRA: Eczema, Pre-existing disease, Urticaria — Feeling: GoodFree text: Increase in Eczema and random hivesMedDRA releases: 2024-11 · check-in free text available
-
2022-01-10
Survey response — days 1–6 daily, dose 1, dependentMedDRA: Eczema, Injection site discolouration — Feeling: GoodFree text: Eczema spots ^^ - spots near injection area tooMedDRA releases: 2024-11 · check-in free text available
- 2022-01-18
-
2022-01-25
Survey response — day 21, dose 1, dependentMedDRA: Exposure to SARS-CoV-2, Oropharyngeal pain — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Sore throat. High risk household contact for Covid-19. Unable to test due to lack of testing supplies and parent isolation.MedDRA releases: 2024-11 · check-in free text available
- 2022-02-02
- 2022-02-08
- 2022-02-15
- 2022-04-05
- 2022-07-05
-
2022-07-06
Dose 2 — Pfizer-BioNTech
-
2022-07-07
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain, Redness · Muscle or body achesAdult check-in
- 2022-07-08
- 2022-07-09
- 2022-07-10
- 2022-07-11
- 2022-07-12
- 2022-07-13
- 2022-07-20
- 2022-07-29
- 2022-08-03
- 2022-08-10
- 2022-08-17
- 2022-10-05
- 2023-01-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-01-04 | Pfizer-BioNTech | No |
| 2 | 2022-07-06 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 1, dependent
Systemic reaction (other): Random hives come and go
Systemic reaction (other): Increase in Eczema and random hives
Systemic reaction (other): Eczema spots ^^ - spots near injection area too
Release 11 — day 21, dose 1, dependent
Symptoms: Sore throat. High risk household contact for Covid-19. Unable to test due to lack of testing supplies and parent isolation.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SRO | Eczema | · | · | ✓ |
| SRO | Injection site discolouration | · | · | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
| SRO | Urticaria | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release